Literature DB >> 15040039

Effects of cholesterol on proliferation and functional protein expression in rabbit bile duct fibroblasts.

Bao-Ying Chen1, Jing-Guo Wei, Yao-Cheng Wang, Jun Yu, Ji-Xian Qian, Yan-Ming Chen, Jing Xu.   

Abstract

AIM: To investigate the effect of cholesterol (Ch) on the growth and functional protein expression of rabbit bile duct fibroblasts.
METHODS: The cultured bile duct fibroblasts were divided randomly into two groups: the control group and the experiment group (fibroblasts were incubated respectively with 0.6 g/L Ch for 12, 24, 36 and 48 h). The growth and DNA synthesis of bile duct fibroblasts were measured by the means of (3)H-TdR incorporation. The total protein content of fibroblast was measured by BSA protein assay reagent kit, then the expression of alpha-actin was analyzed semi-quantitatively by Western blot.
RESULTS: After treatment with 0.6 g/L Ch for 12, 24, 36 and 48 h, the values of (3)H-TdR incorporation of bile duct fibroblasts were respectively 3.1+/-0.39, 3.8+/-0.37, 4.6+/-0.48 and 5.2+/-0.56 mBq/cell, and the values of the corresponding control groups were 3.0+/-0.33, 3.2+/-0.39, 3.7+/-0.49 and 4.3+/-0.43 mBq/cell. After comparing the values of experiment groups and their corresponding control groups, it was found that the (3)H-TdR incorporation of bile duct fibroblasts after treatment with 0.6 g/L Ch for 24, 36 and 48 h were significantly increased (P<0.05, P<0.01, P<0.01), while the (3)H-TdR incorporation of 12-h group was not different statistically from its control group. Ch had no obvious effect on the total protein content of fibroblasts. After incubated with 0.6 g/L Ch for 12, 24, 36 and 48 h, the total protein content of each experiment group was not altered markedly compared with its corresponding control group. The values of experiment groups were 0.246+/-0.051, 0.280+/-0.049, 0.263+/-0.044 and 0.275+/-0.056 ng/cell, and those of corresponding control groups were 0.253+/-0.048, 0.270+/-0.042, 0.258+/-0.050 and 0.270+/-0.045 ng/cell. Western blot analysis revealed that the alpha-actin expression in fibroblasts affected by Ch for 12 and 24 h was not markedly changed compared with their corresponding control groups (P>0.05), the values of total gray scale of 12- and 24-h groups were 1748+/-185 and 1756+/-173, respectively. But after stimulation with Ch for 36 h, the total gray scale of fibroblasts (1923+/-204) was significantly higher than that of control group (1734+/-197). When the time of Ch treatment was lengthened to 48 h, the alpha-actin expression was markedly elevated, the total gray scale was 2 189+/-231 (P<0.01 vs control group).
CONCLUSION: Moderately concentrated Ch can promote the proliferation of bile duct fibroblasts at early stage. With the prolongation of Ch treatment, the alpha-actin expression of fibroblasts was also increased, but the hypertrophy of fibroblasts was not observed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040039      PMCID: PMC4727005          DOI: 10.3748/wjg.v10.i6.889

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Optic properties of bile liquid crystals in human body.

Authors:  Hai-Ming Yang; Jie Wu; Jin-Yi Li; Jian-Li Zhou; Li-Jun He; Xian-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

Review 2.  Myofibroblast differentiation: plasma membrane microdomains and cell phenotype.

Authors:  Jeffery R Schelling; Sumita Sinha; Martha Konieczkowski; John R Sedor
Journal:  Exp Nephrol       Date:  2002

Review 3.  Fibroblast and endothelial apoptosis in systemic sclerosis.

Authors:  Jae-Bum Jun; Melanie Kuechle; John M Harlan; Keith B Elkon
Journal:  Curr Opin Rheumatol       Date:  2003-11       Impact factor: 5.006

4.  [Correction of lipid metabolism in rabbits with experimental cholelithiasis].

Authors:  Iu A Bogdarin; D V Kozlov
Journal:  Vopr Med Khim       Date:  2002 Jul-Aug

Review 5.  Fibroblast phenotypes in pulmonary fibrosis.

Authors:  Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2003-09       Impact factor: 6.914

Review 6.  Electron microscopy in the study of myofibroblastic lesions.

Authors:  Brian Eyden
Journal:  Semin Diagn Pathol       Date:  2003-02       Impact factor: 3.464

7.  Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice.

Authors:  K K Buhman; M Accad; S Novak; R S Choi; J S Wong; R L Hamilton; S Turley; R V Farese
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

8.  Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts.

Authors:  Galina S Bogatkevich; Elena Tourkina; Charles S Abrams; Russell A Harley; Richard M Silver; Anna Ludwicka-Bradley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-03-28       Impact factor: 5.464

9.  The study between the dynamics and the X-ray anatomy and regularizing effect of gallbladder on bile duct sphincter of the dog.

Authors:  Jing-Guo Wei; Yao-Cheng Wang; Guo-Min Liang; Wei Wang; Bao-Ying Chen; Jia-Kuan Xu; Li-Jun Song
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

10.  Ultrasonographic and pathologic features of intestinal smooth muscle hypertrophy in four cats.

Authors:  Alessia Diana; Marco Pietra; Carlo Guglielmini; Andrea Boari; Giuliano Bettini; Mario Cipone
Journal:  Vet Radiol Ultrasound       Date:  2003 Sep-Oct       Impact factor: 1.363

View more
  2 in total

1.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

2.  Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MbetaCD.

Authors:  Li Qin; Yun-Bo Yang; Qin-Hui Tuo; Bing-Yang Zhu; Lin-Xi Chen; Liang Zhang; Duan-Fang Liao
Journal:  Biochem Biophys Res Commun       Date:  2008-12-25       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.